ISFAHAN UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1024-01-01

Employees: -

Market Cap: -

Website: http://www.mui.ac.ir

Clinical Trials

Therapeutic Effects of Silymarin in Patients With B-thalassemia Major

Phase 2

Conditions: Beta-thalassemia Major
Iron Overload

Interventions: Drug: Silymarin (LEGALON)
Drug: Placebo

First Posted Date: 2009-10-21

Last Posted Date: 2009-10-21

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 140

Registration Number: NCT00999349

Locations: 🇮🇷
Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of

Long-Term Effect of Soy Consumption on Cardio-Renal Indices and CRP in Type 2diabetes With Nephropathy

Phase 1

Completed

Conditions: Kidney Transplantation

Interventions: Dietary Supplement: Soy protein

First Posted Date: 2007-11-08

Last Posted Date: 2007-11-08

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 41

Registration Number: NCT00555490

Prevention of Complications of Eye Surgery

Phase 2

Completed

Conditions: Strabismus

First Posted Date: 2007-05-25

Last Posted Date: 2007-05-25

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 300

Registration Number: NCT00478907

Locations: 🇮🇷
Feiz Hospital, Tehran, Isfahan, Iran, Islamic Republic of

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy